DK0750509T4 - Anvendelse af IL-12 og IL 12-antagonister til fremstilling af et farmaceutisk præparat til behandling af autoimmune sygdomme - Google Patents
Anvendelse af IL-12 og IL 12-antagonister til fremstilling af et farmaceutisk præparat til behandling af autoimmune sygdommeInfo
- Publication number
- DK0750509T4 DK0750509T4 DK95912666T DK95912666T DK0750509T4 DK 0750509 T4 DK0750509 T4 DK 0750509T4 DK 95912666 T DK95912666 T DK 95912666T DK 95912666 T DK95912666 T DK 95912666T DK 0750509 T4 DK0750509 T4 DK 0750509T4
- Authority
- DK
- Denmark
- Prior art keywords
- autoimmune
- preparation
- treatment
- antagonists
- autoimmune diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21262994A | 1994-03-14 | 1994-03-14 | |
PCT/US1995/002550 WO1995024918A1 (en) | 1994-03-14 | 1995-03-07 | Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0750509T3 DK0750509T3 (da) | 2002-07-08 |
DK0750509T4 true DK0750509T4 (da) | 2006-10-16 |
Family
ID=22791827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95912666T DK0750509T4 (da) | 1994-03-14 | 1995-03-07 | Anvendelse af IL-12 og IL 12-antagonister til fremstilling af et farmaceutisk præparat til behandling af autoimmune sygdomme |
Country Status (14)
Country | Link |
---|---|
US (1) | US6338848B1 (de) |
EP (4) | EP0750509B2 (de) |
JP (1) | JP3798426B2 (de) |
AT (1) | ATE217533T1 (de) |
AU (1) | AU689236B2 (de) |
CA (1) | CA2185565C (de) |
DE (1) | DE69526728T3 (de) |
DK (1) | DK0750509T4 (de) |
ES (1) | ES2173953T5 (de) |
IL (1) | IL112677A (de) |
PT (1) | PT750509E (de) |
TW (1) | TW400233B (de) |
WO (1) | WO1995024918A1 (de) |
ZA (1) | ZA95960B (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780597A (en) | 1989-12-22 | 1998-07-14 | Hoffmann-La Roche Inc. | Monoclonal antibodies to cytotoxic lymphocyte maturation factor |
US6830751B1 (en) * | 1994-03-14 | 2004-12-14 | Genetics Institute, Llc | Use of IL-12 antagonists in the treatment of rheumatoid arthritis |
US20010055581A1 (en) * | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
US5853697A (en) * | 1995-10-25 | 1998-12-29 | The United States Of America, As Represented By The Department Of Health & Human Services | Methods of treating established colitis using antibodies against IL-12 |
AU4959997A (en) * | 1996-11-15 | 1998-06-10 | Kennedy Institute Of Rheumatology, The | Suppression of tnf alpha and il-12 in therapy |
US6054487A (en) * | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
US7229841B2 (en) | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
US7026456B1 (en) | 1998-01-23 | 2006-04-11 | Hoffman-La Roche, Inc. | Antibodies against human IL-12 |
ES2284242T3 (es) * | 1998-01-23 | 2007-11-01 | F. Hoffmann-La Roche Ag | Anticuerpos contra il-12 humana. |
CA2353520C (en) * | 1998-12-09 | 2006-04-25 | Protein Design Labs, Inc. | Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
AU2460600A (en) | 1999-02-10 | 2000-08-29 | Mitsubishi Pharma Corporation | Amide compounds and medicinal use thereof |
US6914128B1 (en) | 1999-03-25 | 2005-07-05 | Abbott Gmbh & Co. Kg | Human antibodies that bind human IL-12 and methods for producing |
US7883704B2 (en) | 1999-03-25 | 2011-02-08 | Abbott Gmbh & Co. Kg | Methods for inhibiting the activity of the P40 subunit of human IL-12 |
AU2005200515B2 (en) * | 1999-03-25 | 2006-07-13 | AbbVie Deutschland GmbH & Co. KG | Human antibodies that bind human IL-12 and methods for producing |
CA2796140A1 (en) * | 1999-03-25 | 2000-09-28 | Jochen Salfeld | Human antibodies that bind human il-12 and methods for producing |
JP4676049B2 (ja) * | 1999-07-21 | 2011-04-27 | 生化学工業株式会社 | Il−12産生抑制剤 |
US6346247B1 (en) * | 1999-10-28 | 2002-02-12 | Promega Corporation | Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
US7115712B1 (en) | 1999-12-02 | 2006-10-03 | Maxygen, Inc. | Cytokine polypeptides |
US6902734B2 (en) | 2000-08-07 | 2005-06-07 | Centocor, Inc. | Anti-IL-12 antibodies and compositions thereof |
EP1494710A4 (de) * | 2002-03-26 | 2007-03-21 | Centocor Inc | Diabetes-relevante von immunoglobulin stammende proteine, zusammensetzungen, verfahren und verwendungszwecke |
JP2008504216A (ja) | 2003-12-02 | 2008-02-14 | サイトイミューン サイエンシズ インコーポレイテッド | モノクローナル抗体の生成のための方法および組成物 |
GB0329146D0 (en) * | 2003-12-16 | 2004-01-21 | Glaxosmithkline Biolog Sa | Vaccine |
US20070178520A1 (en) * | 2004-02-27 | 2007-08-02 | Barbara Wolff-Winiski | Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors |
EP1778874B1 (de) | 2004-07-30 | 2011-11-23 | Adeza Biomedical Corporation | Onkofetales fibronektin als zervixkarzinom-marker |
CA2591813A1 (en) | 2004-12-21 | 2006-06-29 | Centocor, Inc. | Anti-il-12 antibodies, epitopes, compositions, methods and uses |
WO2007024715A2 (en) | 2005-08-19 | 2007-03-01 | Abbott Laboratories | Dual variable domain immunoglobin and uses thereof |
US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
EP2500354A3 (de) | 2005-08-19 | 2012-10-24 | Abbott Laboratories | Immunglobuline mit zweifacher variabler Domäne und ihre Verwendung |
US7776331B1 (en) | 2007-01-16 | 2010-08-17 | Abbott Laboratories | Methods of treating plaque psoriasis |
CA2681752A1 (en) | 2007-03-29 | 2008-10-09 | Abbott Laboratories | Crystalline anti-human 1l-12 antibodies |
RU2497545C2 (ru) | 2008-03-18 | 2013-11-10 | Эбботт Лэборетриз | Способ лечения псориаза (варианты) |
KR20110014607A (ko) | 2008-04-29 | 2011-02-11 | 아보트 러보러터리즈 | 이원 가변 도메인 면역글로불린 및 이의 용도 |
MX2010013239A (es) | 2008-06-03 | 2011-02-24 | Abbott Lab | Inmunoglobulinas de dominio variable doble y usos de las mismas. |
UY31861A (es) | 2008-06-03 | 2010-01-05 | Abbott Lab | Inmunoglobulina con dominio variable dual y usos de la misma |
MX2010014574A (es) | 2008-07-08 | 2011-04-27 | Abbott Lab | Inmunoglobulinas de dominio variable dual para prostaglandina e2 y usos de las mismas. |
MX2011003347A (es) * | 2008-09-30 | 2011-05-25 | Baylor Res Inst | Metodos para reducir celulas t, b-auxiliares para tratar enfermedades autoinmunes. |
NZ592644A (en) * | 2008-11-28 | 2013-09-27 | Abbott Lab | Stable antibody compositions and methods for stabilizing same |
UY32870A (es) | 2009-09-01 | 2011-02-28 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
MX2012003138A (es) | 2009-09-14 | 2012-07-04 | Abbott Lab Y Abbott Gmbh & Co Kg | Metodos para tratar la psoriasis. |
RU2012119756A (ru) | 2009-10-15 | 2013-11-20 | Эбботт Лэборетриз | Иммуноглобулины с двумя вариабельными доменами и их применение |
UY32979A (es) | 2009-10-28 | 2011-02-28 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
WO2011051466A1 (en) | 2009-11-02 | 2011-05-05 | Novartis Ag | Anti-idiotypic fibronectin-based binding molecules and uses thereof |
WO2012006500A2 (en) | 2010-07-08 | 2012-01-12 | Abbott Laboratories | Monoclonal antibodies against hepatitis c virus core protein |
UY33492A (es) | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
TW201206473A (en) | 2010-08-03 | 2012-02-16 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
JP2013539364A (ja) | 2010-08-26 | 2013-10-24 | アッヴィ・インコーポレイテッド | 二重可変ドメイン免疫グロブリンおよびその使用 |
CA2812310A1 (en) | 2010-09-28 | 2012-04-19 | Neumedicines, Inc. | Uses of il-12 and the il-12 receptor positive cell in tissue repair and regeneration |
JP6009455B2 (ja) | 2010-12-21 | 2016-10-19 | アッヴィ・インコーポレイテッド | Il−1アルファおよびベータ二重特異的二重可変ドメイン免疫グロブリンおよびその使用 |
NO2709651T3 (de) * | 2011-05-19 | 2018-03-03 | ||
WO2013016634A1 (en) * | 2011-07-27 | 2013-01-31 | Neumedicines, Inc. | Use of il-12 to generate endogenous erythropoietin |
MX2014008101A (es) | 2011-12-30 | 2014-09-25 | Abbvie Inc | Proteinas de union especificas duales dirigidas contra il-13 y/o il-17. |
TW201811825A (zh) | 2012-11-01 | 2018-04-01 | 美商艾伯維有限公司 | 抗-vegf/dll4雙重可變區域免疫球蛋白及其用途 |
TW201512219A (zh) | 2013-03-15 | 2015-04-01 | Abbvie Inc | 針對IL-1β及/或IL-17之雙特異性結合蛋白 |
WO2016094881A2 (en) | 2014-12-11 | 2016-06-16 | Abbvie Inc. | Lrp-8 binding proteins |
TW201710286A (zh) | 2015-06-15 | 2017-03-16 | 艾伯維有限公司 | 抗vegf、pdgf及/或其受體之結合蛋白 |
JP7468992B2 (ja) | 2016-03-29 | 2024-04-16 | ヤンセン バイオテツク,インコーポレーテツド | 抗il12及び/又は-23抗体の増加した間隔投与による乾癬の処置 |
TW201922780A (zh) * | 2017-09-25 | 2019-06-16 | 美商健生生物科技公司 | 以抗il12/il23抗體治療狼瘡之安全且有效之方法 |
US11578124B2 (en) | 2018-05-18 | 2023-02-14 | Janssen Biotech, Inc. | Safe and effective method of treating lupus with anti-IL12/IL23 antibody |
FI3883606T3 (fi) | 2018-09-24 | 2023-09-07 | Janssen Biotech Inc | Turvallinen ja tehokas menetelmä haavaisen paksusuolitulehduksen hoitamiseksi anti-il12/il23-vasta-aineella |
JP2022534020A (ja) | 2019-05-23 | 2022-07-27 | ヤンセン バイオテツク,インコーポレーテツド | Il-23及びtnfアルファに対する抗体の併用療法による炎症性腸疾患の治療方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
DK0790309T3 (da) * | 1989-12-22 | 2007-11-05 | Hoffmann La Roche | Cytotoksisk 40kD underenhed af lymfocytmodningsfaktor og monoklonale antistoffer rettet derimod |
GB9207732D0 (en) * | 1992-04-06 | 1992-05-27 | Isis Innovation | Wound repair |
DE4315127A1 (de) * | 1993-05-07 | 1994-11-10 | Behringwerke Ag | Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12 |
CA2125763C (en) * | 1993-07-02 | 2007-08-28 | Maurice Kent Gately | P40 homodimer of interleukin-12 |
EP0638644A1 (de) * | 1993-07-19 | 1995-02-15 | F. Hoffmann-La Roche Ag | Interleukin-12 Rezeptoren und Antikörper |
US5536657A (en) * | 1993-07-19 | 1996-07-16 | Hoffmann-La Roche Inc. | Recombinant DNA encoding human receptor for interleukin-12 |
US5853721A (en) * | 1995-01-31 | 1998-12-29 | Hoffmann-La Roche Inc. | Antibody to interleukin-12 receptor |
BRPI9715219B8 (pt) * | 1996-02-09 | 2015-07-07 | Abbvie Biotechnology Ltd | Vetor recombinante de expressão, e célula hospedeira procariótica. |
US5969102A (en) * | 1997-03-03 | 1999-10-19 | St. Jude Children's Research Hospital | Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
US6054487A (en) * | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
EP0998300A1 (de) * | 1997-03-18 | 2000-05-10 | Basf Aktiengesellschaft | Zusammensetzungen zur modulation der empfänglichkeit für corticosteroiden |
ES2284242T3 (es) * | 1998-01-23 | 2007-11-01 | F. Hoffmann-La Roche Ag | Anticuerpos contra il-12 humana. |
US8700033B2 (en) | 2008-08-22 | 2014-04-15 | International Business Machines Corporation | Dynamic access to radio networks |
CN102377479B (zh) | 2010-08-11 | 2015-01-21 | 华为技术有限公司 | 数据同步方法及系统、光网络单元 |
-
1995
- 1995-02-07 ZA ZA95960A patent/ZA95960B/xx unknown
- 1995-02-14 TW TW084101380A patent/TW400233B/zh not_active IP Right Cessation
- 1995-02-16 IL IL11267795A patent/IL112677A/xx not_active IP Right Cessation
- 1995-03-07 PT PT95912666T patent/PT750509E/pt unknown
- 1995-03-07 JP JP52404495A patent/JP3798426B2/ja not_active Expired - Lifetime
- 1995-03-07 CA CA002185565A patent/CA2185565C/en not_active Expired - Lifetime
- 1995-03-07 EP EP95912666A patent/EP0750509B2/de not_active Expired - Lifetime
- 1995-03-07 EP EP01117762A patent/EP1179348A3/de not_active Withdrawn
- 1995-03-07 WO PCT/US1995/002550 patent/WO1995024918A1/en active IP Right Grant
- 1995-03-07 ES ES95912666T patent/ES2173953T5/es not_active Expired - Lifetime
- 1995-03-07 DE DE69526728T patent/DE69526728T3/de not_active Expired - Lifetime
- 1995-03-07 AU AU19749/95A patent/AU689236B2/en not_active Expired
- 1995-03-07 DK DK95912666T patent/DK0750509T4/da active
- 1995-03-07 EP EP10184543A patent/EP2311484A1/de not_active Withdrawn
- 1995-03-07 EP EP10156687A patent/EP2201959A3/de not_active Withdrawn
- 1995-03-07 AT AT95912666T patent/ATE217533T1/de active
-
2000
- 2000-02-25 US US09/513,380 patent/US6338848B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2185565A1 (en) | 1995-09-21 |
ZA95960B (en) | 1995-10-10 |
EP2201959A2 (de) | 2010-06-30 |
EP0750509B1 (de) | 2002-05-15 |
JP3798426B2 (ja) | 2006-07-19 |
AU689236B2 (en) | 1998-03-26 |
AU1974995A (en) | 1995-10-03 |
JPH09510444A (ja) | 1997-10-21 |
PT750509E (pt) | 2002-08-30 |
EP0750509B2 (de) | 2006-06-14 |
EP0750509A1 (de) | 1997-01-02 |
IL112677A0 (en) | 1995-05-26 |
EP2311484A1 (de) | 2011-04-20 |
US6338848B1 (en) | 2002-01-15 |
DK0750509T3 (da) | 2002-07-08 |
TW400233B (en) | 2000-08-01 |
DE69526728D1 (de) | 2002-06-20 |
CA2185565C (en) | 2009-02-03 |
EP1179348A3 (de) | 2003-12-03 |
IL112677A (en) | 2000-01-31 |
DE69526728T3 (de) | 2007-01-04 |
DE69526728T2 (de) | 2002-11-21 |
WO1995024918A1 (en) | 1995-09-21 |
EP1179348A2 (de) | 2002-02-13 |
ATE217533T1 (de) | 2002-06-15 |
ES2173953T5 (es) | 2007-03-01 |
EP2201959A3 (de) | 2011-03-16 |
ES2173953T3 (es) | 2002-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0750509T3 (da) | Anvendelse af IL-12 og IL 12-antagonister til fremstilling af et farmaceutisk præparat til behandling af autoimmune sygdomme | |
Saxne et al. | Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis | |
ATE411029T1 (de) | Estrogene als antimitotika | |
WO1994007535A3 (en) | Labelled interleukin-8 and medical uses thereof | |
DK0707487T3 (da) | Fremgangsmåder og farmaceutiske præparater, der er nyttige til behandling af neurologiske lidelser | |
FR2726191B1 (fr) | Dispositif de traitement du syndrome d'apnee pendant le sommeil | |
DE69325998D1 (de) | Verwendung von beta-hydroxy-beta-methylbutyratsäuere zur förderung der stickstoffzurückhaltung beim menschen | |
DE69022501D1 (de) | Verwendung eines Amylinantagonisten zur Herstellung eines Artzneimittels zur Behandlung von Fettsucht und essentieller Hypertonie und damit zusammenhängenden Krankheiten. | |
IT1229506B (it) | Polimero dell'acido acrilico esente da solventi residui e procedimento per la sua preparazione. | |
FR2667076B1 (fr) | Procede et appareil pour la fabrication d'un aminoacide par fermentation. | |
DK0413329T3 (da) | 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme | |
SE9402370D0 (sv) | Use of IGF-I | |
NO925048D0 (no) | Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet | |
Kirk et al. | A brief inservice training strategy to increase levels of empathy of psychiatric nursing personnel. | |
Rosenbaum | Treating hair pulling in a 7-year-old male: Modified habit reversal for use in pediatric settings | |
OA08298A (fr) | Nouvelles N-(aminométhyl-5 oxazolin-2 yl-2) N'-phénylurées, leur méthode de préparation ainsi que leur application thérapeutique. | |
KR910009255A (ko) | 과트리글리세라이드혈증과, 콜레스테롤혈증, 저레벨의 hdl질환 및 아테롬성 동맥경화증 치료제로서 사용되는 2-(페녹시 프로파놀아미노)에톡시 페녹시아세트산 유도체 | |
IT7950444A0 (it) | N-(1-metil 2-pirrolidinilmetil) 2,3dimetossi-5-metilsolfamoil benzammide e suoi derivati utili per il trattamento dei disturbi dell'appa rato urinario e procedimento di preparazione | |
Sakamoto et al. | A Case Report of Multiple Tendon Xanthomas | |
Zuk | Methodology for evaluating the aesthetic appeal of bridge designs | |
IT8421534A0 (it) | Esteri dell'acido acetico eterociclici e relativo procedimento di fabbricazione. | |
Heye et al. | Investigation of use of alternative treatment methods by patients with rheumatoid arthritis | |
Smith | Using behavioral methods in the management of disturbed elderly patients in an auxiliary hospital | |
Verhaeghe | Platelets in peripheral arterial disease | |
Tohyama et al. | Long-Term Functional Prognosis and CT Findings of Patients with Crush Syndrome from the Hanshin-Awaji Earthquake |